Digestive Health

Articles

Clasado Biosciences has announced that the European Food Safety Authority (EFSA) has given a positive opinion on the extension of the use of galactooligosaccharises (GOS) as a novel food in food for special medical purposes (‘FSMP’) in the EU. 

EFSA offers positive opinion for use of Bimuno GOS in food for special medical purposes

A whole host of emerging actives—some familiar; others less so—are vying for ground in the crowded immune-support category.

Immune health: New, novel ingredients are on the scene. Can they take on the market’s old guard?

The new funding will enable Brightseed to advance natural compound discovery and clinical validation, as well as launch the company’s first generally recognized as safe (GRAS) ingredient from a new commercialization center in Raleigh, North Carolina. 

Brightseed announces new funding, which will finance further discovery and commercialization

In May 2021, the International Scientific Association for Probiotics and Prebiotics (ISAPP) formally defined what, operationally speaking, a postbiotic is. So what does this signal for the postbiotics market?

Postbiotic Progress: Definitional clarity moves the postbiotic field forward

Results showed that the enzyme blend more effectively released nutrients from a balanced meal compared to control conditions, which relied solely on endogenous enzymes similar to those already present in the human digestive system.

Multi-enzyme blend tested and validated using new in vitro model that simulates digestion

Nexira will present four new scientific studies on gut health, urinary comfort, beauty from within, and sports nutrition at VitaFoods Europe 2022, taking place on May 10-12. 

Nexira to showcase new research at VitaFoods Europe 2022

The firm is also unveiling a range of new functional food applications for its Collavat n2 native (undenatured) type II collagen ingredient for joint health. 

Bioiberica to debut new digestive health and beauty ingredients at Vitafoods Europe 2022

Melissa Kvidahl Reilly is a freelance journalist and copywriter specializing in the health and wellness industry.

There’s no limit to the potential popularity of products designed for microbiome support. The only thing standing in their way right now is the availability of clinical research.

Microbiome market: Research and education are the keys

Alissa Marrapodi is Industry Insights Contributor, Custom Content Editor, MJH Life Sciences.

Maypro has joined the International Probiotics Association.

Maypro becomes a member of IPA

Chad Larson, NMD, DC, CCN, CSCS, is an advisor and consultant on the clinical consulting team for 

 (Phoenix, AZ). Cyrex Laboratories, a clinical laboratory specializing in functional immunology and autoimmunity, has developed a test panel called the 

Alzheimer’s LINX Alzheimer’s-Associated Immune Reactivity

. This test can help clinicians identify patients at greater risk and reactivity triggers for developing Alzheimer’s disease or other neurological disorder. It can also be used to identify early stages of the neurodegenerative processes and monitor the effectiveness of lifestyle modifications. The Alzheimer’s LINX is recommended for patients who have a family history of Alzheimer’s disease or are exhibiting early signs of Alzheimer’s disease, have been diagnosed with Alzheimer’s, or who have a history of gastrointestinal disorders or type 2 diabetes. Dr. Larson holds a Doctor of Naturopathic Medicine degree from Southwest College of Naturopathic Medicine and a Doctor of Chiropractic degree from Southern California University of Health Sciences. He is a certified clinical nutritionist and a certified strength and conditioning specialist. He particularly pursues advanced developments in the fields of endocrinology, orthopedics, sports medicine, and environmentally induced chronic disease.

Some of the ways to lower our risk of developing this cognitive impairment may surprise you—and they have to do with diet and nutrition.